Effect of diamide and reduced glutathione on the elevated levels of cyclic AMP in rat pancreatic islets exposed to glucose, p-chloromercuribenzoate and aminophylline

  • H. P. T. Ammon
  • S. Heinzl
  • M. Abdel-Hamid
  • H. -M. Kallenberger
  • I. Hagenloh
Article

Summary

In rat pancreatic islets the effects of diamide, which has been shown to decrease islet levels of reduced glutathione (GSH), and of exogenous GSH were investigated on cyclic AMP as increased by glucose, p-chloromercuribenzoate, and aminophylline. In addition the effect of diamide on islet ATP level, low K m and high K m phosphodiesterases was studied.

Diamide (0.1 mM) inhibited the increase of cyclic AMP (cAMP) in response to glucose (16.7 mM), and p-chloromercuribenzoate (1 mM) in the presence of 5.6 mM glucose. No inhibitory effect of diamide could be demonstrated when cAMP was raised by 10 mM aminophylline in the presence of 5.6 mM glucose. The glucose (27.7 mM) stimulated increase of cAMP was further augmented by GSH (0.4 mM) whereas GSH in the presence of 5.6 mM glucose had no such effect. Diamide neither affected islet high K m nor low K m cAMP-phosphodiesterases. Diamide (0.1 mM) as used in this study did not affect islet AMP levels.

A concentration dependent decrease of ATP was observed, however, with higher concentrations of diamide (0.25, 0.5 and 1.0 mM).

It is suggested that the accumulation of islet cAMP in response to glucose and para-chloromercuribenzoate depends on the redox state of islet thiols. Since thiol oxidant diamide neither affected cAMP-phosphodiesterase activities nor inhibited aminophylline induced accumulation of cAMP in the presence of low glucose the possibility is raised that in pancreatic islets the formation of cAMP rather than its degradation depends on the redox state of islet thiols.

Key words

Islet of Langerhans cAMP, cAMP-Phosphodiesterase Glucose p-Chloromercuribenzoate Thiol oxidant Reduced glutathione 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ammon HPT, Abdel-Hamid M (1981) Potentiation of the insulin releasing capacity of tolbutamide by thiols; studies on the isolated perfused pancreas. Naunyn-Schmiedeberg's Arch Pharmacol 317: 262–267Google Scholar
  2. Ammon HPT, Heinzl S (1979) A possible role of thiols in glucose- and glucagon-mediated increase of cAMP in isolated rat pancreatic islets. Excerpta Med 7:481 (Abstract)Google Scholar
  3. Ammon HPT, Verspohl E (1976) Pyridine nucleotides in pancreatic islets during inhibition of insulin release by exogenous insulin. Endocrinology 99:1469–1476Google Scholar
  4. Ammon HPT, Akhtar MS, Niklas H, Hegner D (1977) Inhibition of p-chloromercuribenzoate- and glucose-induced insulin release in vitro by methylene blue, diamide and tert-butyl hydroperoxide. Mol Pharmacol 13:598–605Google Scholar
  5. Ammon HPT, Akhtar MS, Grimm A, Niklas H (1970) Effect of methylene blue and thiol oxidants on pancreatic islet GSH/GSSG ratios and tolbutamide mediated insulin release in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 307:91–96Google Scholar
  6. Ammon HPT, Grimm A, Lutz S, Wagner-Teschner D, Händel M, Hagenloh I (1980) Islet glutathione and insulin release. Diabetes 29: 830–834Google Scholar
  7. Ammon HPT, Hoppe E, Akhtar MS, Niklas H (1979b) Effect of leucine on the pyridine nucleotide contents of islets and on the insulin released-interactions in vitro with methylene blue, thiol oxidants, and p-chloromercuribenzoate. Diabetes 28:593–599Google Scholar
  8. Baba A, Lee E, Matsuda T, Kihara T, Iwata H (1978) Reversible inhibition of adenylate cyclase activity of rat brain caudate nucleus by oxidized glutathione. Biochem Biophys. Res Commun 85:1204–1210Google Scholar
  9. Beckmann J, Holze S, Lenzen S, Panten U (1981) Quantification of cells in islets of Langerhans using DNA determination. Acta Diabet Lat 18:51–57Google Scholar
  10. Bloom GD, Hellman B, Idahl L-A, Lernmark A, Sehlin J, Täljedal I-B (1972) Effects of organic mercurials on mammalian pancreatic β-cells. Insulin release, glucose transport, glucose oxidation, membrane permeability and ultrastructure. Biochem J 129:241–254Google Scholar
  11. Claro A, Grill V, Efendic S, Luft R (1977) Studies on the mechanisms of somatostatin action on insulin release. IV. Effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated pancreatic islets. Acta Endocrinol 85:379–388Google Scholar
  12. Charles MA, Fanska R, Schmid F, Forsham PH, Grodsky GM (1973) Adenosine 3′5′-monophosphate in pancreatic islets: glucose-induced insulin release. Science 179:569–571Google Scholar
  13. Charles MA, Lawecki J, Pictet R, Grodsky GM (1975) Insulin secretion. Interrelationships of glucose, cyclic adenosine 3′∶5′-monophosphate and calcium. J Biol Chem 250:6134–6140Google Scholar
  14. Cooper RH, Ashcroft SJH, Randle PJ (1973) Concentration of adenosine 3′5′-cyclic monophosphate in mouse pancreatic islets method by protein binding radioassay. Biochem J 134:599–605Google Scholar
  15. Grill V, Cerasi E (1974) Stimulation by d-glucose of cyclic 3′5′-adenosine monophosphate accumulation and insulin release in isolated pancreatic islets of the rat. J Biol Chem 249:4196–4201Google Scholar
  16. Grill V, Cerasi E (1978) Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat. J Clin Invest 61:1346–1354Google Scholar
  17. Haest CWM, Kamp D, Deuticke B (1979) Formation of disulfide bonds between glutathione and membrane SH-groups in human erythrocytes. Biochim Biophys Acta 557:363–371Google Scholar
  18. Harper JF, Brooker G (1975) Femtomole sensitive radioimmunoassay forcyclic AMP and cyclic GMP after 2′0 acetylation by acetic anhydride in aqueous solution. J Cycl Nucl Res 1:207–218Google Scholar
  19. Hellman B, Idahl L-A, Lernmark A, Täljedahl IB (1974) The pancreatic β-cell recognition of insulin secretagogues. Does cyclic AMP mediate the effect of glucose?. Proc Natl Acad Sci (Wash) 71:3405–3409Google Scholar
  20. Hellman B, Idahl L-A, Lernmark A, Sehlin J, Täljedal I-B (1973) Role of thiol groups in insulin release. Studies with poorly permeating disulphides. Mol Pharmacol 9:792–801Google Scholar
  21. Isaacs JT, Binkley F (1977) Glutathione dependent control of protein disulfide-sulfhydryl content by subcellular fractions of hepatic tissue. Biochem Biophys Acta 497:192–204Google Scholar
  22. Johnson RA, Hardman JG, Broadus AE, Sutherland EW (1970) Analysis of adenosine 3′,5′-monophosphate with luciferase luminescence. Anal Biochem 35:91–97Google Scholar
  23. Kallenberger H-M, Ammon HPT (1980) cAMP phosphodiesterase (PDEs) of rat pancreatic islets: Effect of calcium, glucose, and insulin. Diabetologia 18 (Abstract)Google Scholar
  24. Kissane JM, Robins E (1958) The fluorimetric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 233:184–188Google Scholar
  25. Kosower NS, Kosower EM, Wertheim B, Correa WS (1969) Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochem Biophys Res Commun 37:593–596Google Scholar
  26. Kuo WN, Hodgins D, Kuo JF (1974) Regulation by various hormones and agents of adenosine-3′5′-monophosphate levels in islets of Langerhans of rats. Biochem Pharmacol 23:1387–1391Google Scholar
  27. Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35–39Google Scholar
  28. Lambert AE, Kanazawa Y, Burr IM, Orci L, Renold AE (1977) On the role of cyclic AMP in insulin release. I. Overall effects in cultured fetal rat pancreas. Ann NY Acad Sci 185:232–244Google Scholar
  29. Malaisse WJ, Malaisse-Lagae F, Mayhew D (1967) A possible role for the adenyl cyclase system in insulin secretion. J Clin Invest 46: 1724–1734Google Scholar
  30. Mavier P, Hanoune J (1975) Adenylate cyclase from rat-liver plasma membrane: inhibition by mersalyl and other mercurial derivatives. Eur J Biochem 59:593–599Google Scholar
  31. Montague E, Cook TR (1971) The role of adenosine 3′,5′-cyclic monophosphate in the regulation of insulin release by isolated rat islets of Langerhans. Biochem J 122:115–120Google Scholar
  32. Mukherjee SP, Lynn WS (1977) Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin. Possible role in the hormone's effect on adenylate cyclase and the hexose monophosphate shunt. Arch Biochem Biophys 184:69–76Google Scholar
  33. Mukherjee SP, Lynn WS (1979) Role of cellular redox state and glutathione in adenylate cyclase activity in rat adipocytes. Biochem Biophys Acta 568:224–233Google Scholar
  34. Rink H (1974) In: Flohe L, Benöhr H, Sies H, Waller HD, Wendel A (eds) Glutathione proceedings of the 16th conference of the german society of biological chemistry. Thieme Stuttgart, p 213Google Scholar
  35. Schauder P, Arends J, Schindler B, Ebert R, Frerichs H (1977) Permissive effect of glucose on the glucagon-induced accumulation of cyclic AMP in isolated rat pancreatic islets. Diabetologia 13:171–175Google Scholar
  36. Storm DR, Dolginow YD (1973) Glucagon stimulation of adenylate cyclase sulfhydryl reactivity. Evidence for hormone-induced conformational changes. J Biol Chem 248:5208–5210Google Scholar
  37. Storm DR, Gunsalus RP (1974) Methylmercury is a potent inhibitor of membrane adenyl cyclase. Nature 250:778–779Google Scholar
  38. Zawalich WS, Karl RC, Ferrendelli JA, Matschinsky FM (1975) Factors governing glucose induced elevation of cyclic 3′5-AMP levels in pancreatic islets. Diabetologia 11:231–235Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • H. P. T. Ammon
    • 1
  • S. Heinzl
    • 1
  • M. Abdel-Hamid
    • 1
  • H. -M. Kallenberger
    • 1
  • I. Hagenloh
    • 1
  1. 1.Department of Pharmacology, Institute of Pharmaceutical SciencesUniversity of TübingenTübingenGermany

Personalised recommendations